The Market Reports

Index

1 Opioids Market Overview
1.1 Product Overview and Scope of Opioids
1.2 Opioids Segment by Type
1.2.1 Global Opioids Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Segment by Application
1.3.1 Global Opioids Sales Comparison by Application: (2021-2027)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size Estimates and Forecasts
1.4.1 Global Opioids Revenue 2016-2027
1.4.2 Global Opioids Sales 2016-2027
1.4.3 Opioids Market Size by Region: 2016 Versus 2021 Versus 2027

2 Opioids Market Competition by Manufacturers
2.1 Global Opioids Sales Market Share by Manufacturers (2016-2021)
2.2 Global Opioids Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioids Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioids Manufacturing Sites, Area Served, Product Type
2.5 Opioids Market Competitive Situation and Trends
2.5.1 Opioids Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Opioids Players Market Share by Revenue
2.5.3 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Opioids Retrospective Market Scenario by Region
3.1 Global Opioids Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Opioids Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Opioids Market Facts & Figures by Country
3.3.1 North America Opioids Sales by Country
3.3.2 North America Opioids Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioids Market Facts & Figures by Country
3.4.1 Europe Opioids Sales by Country
3.4.2 Europe Opioids Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioids Market Facts & Figures by Region
3.5.1 Asia Pacific Opioids Sales by Region
3.5.2 Asia Pacific Opioids Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioids Market Facts & Figures by Country
3.6.1 Latin America Opioids Sales by Country
3.6.2 Latin America Opioids Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Opioids Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioids Sales by Country
3.7.2 Middle East and Africa Opioids Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioids Historic Market Analysis by Type
4.1 Global Opioids Sales Market Share by Type (2016-2021)
4.2 Global Opioids Revenue Market Share by Type (2016-2021)
4.3 Global Opioids Price by Type (2016-2021)

5 Global Opioids Historic Market Analysis by Application
5.1 Global Opioids Sales Market Share by Application (2016-2021)
5.2 Global Opioids Revenue Market Share by Application (2016-2021)
5.3 Global Opioids Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Opioids Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Purdue Pharma Opioids Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Opioids Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amneal Pharma Opioids Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Collegium Opioids Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Sales, Revenue and Gross Margin (2016-2021)
6.6.4 J&J Opioids Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Endo Opioids Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Opioids Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2016-2021)
6.9.4 INSYS Opioids Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Mylan Opioids Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Description and Business Overview
6.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hikma Opioids Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Description and Business Overview
6.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Egalet Opioids Product Portfolio
6.12.5 Egalet Recent Developments/Updates

7 Opioids Manufacturing Cost Analysis
7.1 Opioids Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioids
7.4 Opioids Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioids Distributors List
8.3 Opioids Customers

9 Opioids Market Dynamics
9.1 Opioids Industry Trends
9.2 Opioids Growth Drivers
9.3 Opioids Market Challenges
9.4 Opioids Market Restraints

10 Global Market Forecast
10.1 Opioids Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioids by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Opioids by Type (2022-2027)
10.2 Opioids Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioids by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Opioids by Application (2022-2027)
10.3 Opioids Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioids by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Opioids by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Opioids Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Opioids Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Opioids Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Opioids Covered in This Study
Table 5. Global Opioids Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Opioids Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Opioids Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Opioids Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Opioids Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Opioids Manufacturing Sites and Area Served
Table 11. Manufacturers Opioids Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Opioids Sales by Region (2016-2021) & (MT)
Table 16. Global Opioids Sales Market Share by Region (2016-2021)
Table 17. Global Opioids Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Opioids Sales by Country (2016-2021) & (MT)
Table 19. North America Opioids Sales Market Share by Country (2016-2021)
Table 20. North America Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Opioids Revenue Market Share by Country (2016-2021)
Table 22. Europe Opioids Sales by Country (2016-2021) & (MT)
Table 23. Europe Opioids Sales Market Share by Country (2016-2021)
Table 24. Europe Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Opioids Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Opioids Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Opioids Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Opioids Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Opioids Revenue Market Share by Region (2016-2021)
Table 30. Latin America Opioids Sales by Country (2016-2021) & (MT)
Table 31. Latin America Opioids Sales Market Share by Country (2016-2021)
Table 32. Latin America Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Opioids Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Opioids Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Opioids Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Opioids Revenue Market Share by Country (2016-2021)
Table 38. Global Opioids Sales (MT) by Type (2016-2021)
Table 39. Global Opioids Sales Market Share by Type (2016-2021)
Table 40. Global Opioids Revenue (Million US$) by Type (2016-2021)
Table 41. Global Opioids Revenue Share by Type (2016-2021)
Table 42. Global Opioids Price (USD/Kg) by Type (2016-2021)
Table 43. Global Opioids Sales (MT) by Application (2016-2021)
Table 44. Global Opioids Sales Market Share by Application (2016-2021)
Table 45. Global Opioids Revenue (Million US$) by Application (2016-2021)
Table 46. Global Opioids Revenue Share by Application (2016-2021)
Table 47. Global Opioids Price (USD/Kg) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Teva Opioids Product
Table 52. Teva Recent Developments/Updates
Table 53. Purdue Pharma Corporation Information
Table 54. Purdue Pharma Description and Business Overview
Table 55. Purdue Pharma Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Purdue Pharma Opioids Product
Table 57. Purdue Pharma Recent Developments/Updates
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Mallinckrodt Opioids Product
Table 62. Mallinckrodt Recent Developments/Updates
Table 63. Amneal Pharma Corporation Information
Table 64. Amneal Pharma Description and Business Overview
Table 65. Amneal Pharma Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Amneal Pharma Opioids Product
Table 67. Amneal Pharma Recent Developments/Updates
Table 68. Collegium Corporation Information
Table 69. Collegium Description and Business Overview
Table 70. Collegium Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Collegium Opioids Product
Table 72. Collegium Recent Developments/Updates
Table 73. J&J Corporation Information
Table 74. J&J Description and Business Overview
Table 75. J&J Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. J&J Opioids Product
Table 77. J&J Recent Developments/Updates
Table 78. Endo Corporation Information
Table 79. Endo Description and Business Overview
Table 80. Endo Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Endo Opioids Product
Table 82. Endo Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Pfizer Opioids Product
Table 87. Pfizer Recent Developments/Updates
Table 88. INSYS Corporation Information
Table 89. INSYS Description and Business Overview
Table 90. INSYS Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. INSYS Opioids Product
Table 92. INSYS Recent Developments/Updates
Table 93. Mylan Corporation Information
Table 94. Mylan Description and Business Overview
Table 95. Mylan Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Mylan Opioids Product
Table 97. Mylan Recent Developments/Updates
Table 98. Hikma Corporation Information
Table 99. Hikma Description and Business Overview
Table 100. Hikma Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Hikma Opioids Product
Table 102. Hikma Recent Developments/Updates
Table 103. Egalet Corporation Information
Table 104. Egalet Description and Business Overview
Table 105. Egalet Opioids Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Egalet Opioids Product
Table 107. Egalet Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Opioids Distributors List
Table 111. Opioids Customers List
Table 112. Opioids Market Trends
Table 113. Opioids Growth Drivers
Table 114. Opioids Market Challenges
Table 115. Opioids Market Restraints
Table 116. Global Opioids Sales Forecast by Type (2022-2027) & (MT)
Table 117. Global Opioids Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Opioids Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Opioids Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Opioids Sales Forecast by Application (2022-2027) & (MT)
Table 121. Global Opioids Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Opioids Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Opioids Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Opioids Sales Forecast by Region (2022-2027) & (MT)
Table 125. Global Opioids Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Opioids Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Opioids Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioids
Figure 2. Global Opioids Market Share by Type in 2020 & 2027
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Market Share by Application in 2020 & 2027
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Cough Suppression
Figure 12. Diarrhea Suppression
Figure 13. Deaddiction
Figure 14. Others
Figure 15. Global Opioids Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Opioids Market Size 2016-2027 (US$ Million)
Figure 17. Global Opioids Sales 2016-2027 (MT)
Figure 18. Global Opioids Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Opioids Sales Share by Manufacturers in 2020
Figure 20. Global Opioids Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Opioids Players: Market Share by Revenue in 2020
Figure 22. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Opioids Sales Market Share by Region (2016-2021)
Figure 24. Global Opioids Sales Market Share by Region in 2020
Figure 25. Global Opioids Revenue Market Share by Region (2016-2021)
Figure 26. Global Opioids Revenue Market Share by Region in 2020
Figure 27. U.S. Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Opioids by Type (2016-2021)
Figure 52. Sales Market Share of Opioids by Application (2016-2021)
Figure 53. Sales Market Share of Opioids by Application in 2020
Figure 54. Revenue Share of Opioids by Application (2016-2021)
Figure 55. Revenue Share of Opioids by Application in 2020
Figure 56. Manufacturing Cost Structure of Opioids
Figure 57. Manufacturing Process Analysis of Opioids
Figure 58. Opioids Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed